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ABSTRACT 
In the present work effect of methyl-β-cyclodextrin (MβCD) on physical properties and dissolution rate of Irbesartan (IRB) was 
studied.Based on AL-type ofphase solubility diagram obtained; solid binary systems of the drug with MβCD were prepared in 1:1 
molar ratio by various methods. Complexes were characterized using Differential Scanning Calorimetry and powder X-Ray 
Diffractometry. It could be concluded that IRB can form inclusion complex with MβCD. The dissolution profiles of inclusion 
complexes were compared with those of IRB alone and the physical mixture. The dissolution rate of IRB was increased remarkably 
by MβCD inclusion complexation. 
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INTRODUCTION: 
Irbesartan (IRB) is used in the treatment of 
hypertension. Its poor aqueous solubility leads to limited 
bioavailability after oral administration
1, 2
. 
Cyclodextrins (CDs) are macrocyclic oligosaccharides 
with six to eight D-glucose units called α- cyclodextrin, 
β- cyclodextrin and γ-cyclodextrin and have been widely 
used to improve the solubility and dissolution rate of 
poorly soluble drugs
3
. Significant improvement in the 
solubility resulting in increased rate of dissolution and 
absorbability is obtained by use of methylated βCD. 
Co-evaporation, co-grindingandkneadingmethods were 
used to prepareinclusion complexes. Instrumental 
techniques like X-Ray Diffraction (XRD) and 
Differential Scanning Calorimetry (DSC) were used for 
characterization of complexes. Dissolution patterns of 
plain drug, physical mixtures and inclusion complexes 
were evaluated. 
MATERIALS AND METHODS: 
Materials: IRB was kindly supplied byAarati Drugs 
Ltd., India. MβCD (D.S. = 1.8 and M. W. = 1310) was 
gifted by Wacker fine chemicals.  
Methods: Method described by Higuchi and Connors 
was used to conduct phase solubility studies
1
. An excess 
amount of IRB was added to MβCD aqueous solution 
(0-10mM) and subjected to shaking. After equilibrium 
attainment, concentration of IRB was determined. The 
apparent stability constant Ks was calculated from the 
phase solubility diagram according to the following 
equation: 
Ks = 
)1( SlopeS
Slope
o 
 
S0 is the solubility of IRB in absence of MβCD. 
Preparation and evaluation of Binary Systems of 
IRB–MβCD: 
Various methods such as co-grinding (CG), kneading 
(KN) and co-evaporation (CE) were used to prepare 
binary systems of IRB-MβCD with 1:1 molar ratio. The 
physical mixture (PM) was also prepared for the 
purpose of comparison. Intense trituration of IRB and 
MβCD was carried out to obtain CG product. Trituration 
of IRB with MβCD in glass mortar followed by 
kneading with 66% alcohol for 45 minresulted in KN 
product. The pasty mass obtained was dried at 60°C. 
The dried mass was passed through sieve no.80 and 
stored overnight in desiccator. For preparation of CE 
product, equimolar amounts of MβCD and IRB were 
dissolved in minimum volume of 1:1 mixture of 66% 
ethanol and water. The final solution was stirred with 
the help of magnetic stirrer at 60°C till pasty mass was 
obtained. The pasty mass was treated as above to get the 
dry sample. 
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Binary systems were characterized by DSC, XRD 
alongwith dissolution studies. Dissolution rate studies of 
IRB alone and from various IRB-MβCD systems were 
conducted using USP XXIII dissolution apparatus type-
II (6 stations, VDA-6DR, Veego Scientific, India) at 37 
+ 0.5°C stirring at 50 rpm. Seventy five mg of IRB or its 
equivalent amount of IRB-MβCD binary system was 
added to 1000 ml of distilled water. At predetermined 
time intervals, the samples were withdrawn and 
analyzed spectrophotometrically. 
RESULTS AND DISCUSSION: 
The phase solubility profile of IRB-MβCD as presented 
in Figure1 is classified as AL type. The curve showed a 
linear increase in IRB solubility as a function of MβCD 
concentration with a slope of 0.0904 (R
2
 = 0.999) in the 
concentration range (0-10 mM) investigated. The 
apparent stability constant K1:1 was 177.8 M
-1
. Slope 
value was lower than one indicating inclusion complex 
in the molar ratio of 1:1. 
 
Figure 1: Phase solubility profile of IRB-MβCD in 
water 
Thermograms of IRB and the binary systems are shown 
in Fig. 2. The thermogram of IRB was typical of a 
highly crystalline compound, characterized by a sharp 
endothermic peak at 181°C, corresponding to its 
melting. A broad endotherm in the range of 100-120°C 
in case of MβCD indicated release of water molecule 
from its cavity. PM and CG systems showed retention 
endothermic peaks corresponding to drug whereas it was 
shifted to lower temperature in the case of CE system. 
KN system showed a significant shift in location of 
endothermic peak of IRB to 158.9ºC with substantial 
broadening which can be attributed to complex 
formation 
5
. 
Thus kneading method can be utilized for complexation 
of IRB using MβCD. 
XRD patterns of IRB, PM and KN complex are 
illustrated in Fig. 3. Two broad diffused peak of MβCD 
indicated its amorphous nature. PM and CG systems 
showed peaks attributable to IRB. The KN and CE 
systems exhibited more diffused diffraction patterns, 
indicating loss of crystallinity. Similar disappearance of 
crystalline drug peak was observed by Bandi et al in 
case of HPβCD complexation of some drugs 5. 
 
Figure 2: DSC thermograms of IRB-MβCD systems: 
Irbesartan (IRB), Methyl-β-cyclodextrin (MβCD), 
physical mixture (PM), co-ground (CG), co-evaporated 
(CE) and kneaded (KN) systems 
 
 
Figure 3: X-Ray Diffractograms of IRB-MβCD 
systems: Irbesartan (IRB), Methyl-β-cyclodextrin 
(MβCD),    physical mixture (PM), Co-ground (CG), co-
evaporated (CE) and kneaded (KN) systems 
Dissolution Studies 
Amongst the IRB-MβCD systems, KN system showed 
the highest improvement in the dissolution rate. Thus it 
can be concluded that KN method was more efficient in 
improving the solubility when using MβCD. The KN 
method is of the particular interest for industrial scale 
preparations because of the low cost and the simple 
process, which involves less energy, time and 
equipment. 
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Figure 4: The dissolution diagram of IRB-MβCD systems 
Irbesartan (IRB), physical mixture (PM), co-ground (CG), co-evaporated (CE),  kneaded (KN) systems 
 
CONCLUSION: 
From instrumental methods of characterization, it can be 
concluded that IRB forms inclusion complexes with 
MβCD. The complexes exhibited improvement in 
solubility and dissolution rate of drug.  
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